Maravai Stock Dips Monday With Eyes on Major Event This Week
Maravai LifeSciences shares fell 0.6% to $4.77 in early Monday trading, though the stock remains up 47% for the year. First-quarter revenue rose 40.5% to $65.8 million, with net loss narrowing to $6.4 million. CFO Raj Asarpota will speak at the Jefferies Global Healthcare Conference on June 4. The company raised its 2026 revenue outlook to $205–215 million.
